These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 1548577)
1. Identifying HIV-2-seropositive individuals by reevaluating HIV-1 indeterminate sera. Myers RA; Patel JD; Joseph JM J Acquir Immune Defic Syndr (1988); 1992; 5(4):417-23. PubMed ID: 1548577 [TBL] [Abstract][Full Text] [Related]
2. Multicenter evaluation of a new recombinant enzyme immunoassay for the combined detection of antibody to HIV-1 and HIV-2. Ayres L; Avillez F; Garcia-Benito A; Deinhardt F; Gürtler L; Denis F; Léonard G; Ranger S; Grob P; Joller-Jemelka H AIDS; 1990 Feb; 4(2):131-8. PubMed ID: 2183814 [TBL] [Abstract][Full Text] [Related]
3. Frequency of human immunodeficiency virus (HIV) infection among contemporary anti-HIV-1 and anti-HIV-1/2 supplemental test-indeterminate blood donors. The Retrovirus Epidemiology Donor Study. Busch MP; Kleinman SH; Williams AE; Smith JW; Ownby HE; Laycock ME; Lee LL; Pau CP; Schreiber GB Transfusion; 1996 Jan; 36(1):37-44. PubMed ID: 8607151 [TBL] [Abstract][Full Text] [Related]
4. Evidence of serological cross-reactivities with human immunodeficiency virus types 1 and 2 and human T-lymphotropic virus types I and II in sera of pregnant women in Ibadan, Nigeria. Olaleye DO; Ekweozor CC; Sheng Z; Rasheed S Int J Epidemiol; 1995 Feb; 24(1):198-203. PubMed ID: 7797344 [TBL] [Abstract][Full Text] [Related]
6. Reliable confirmation and quantitation of human immunodeficiency virus type 1 antibody using a recombinant-antigen immunoblot assay. Busch MP; el Amad Z; McHugh TM; Chien D; Polito AJ Transfusion; 1991 Feb; 31(2):129-37. PubMed ID: 1899951 [TBL] [Abstract][Full Text] [Related]
7. Rapid and simple screening and supplemental testing for HIV-1 and HIV-2 infections in west Africa. Brattegaard K; Kouadio J; Adom ML; Doorly R; George JR; De Cock KM AIDS; 1993 Jun; 7(6):883-5. PubMed ID: 8395857 [TBL] [Abstract][Full Text] [Related]
8. Occurrence, characteristics, and patterns of HIV-1 and HIV-2 western blot indeterminate sera in low risk populations in West Virginia and pre-AIDS Africa. Schindzielorz AH; Belshe RB; Mufson MA Am J Trop Med Hyg; 1990 May; 42(5):460-4. PubMed ID: 2187367 [TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of HIV-1 and HIV-2 indeterminate western blot patterns. Ayisi NK; Aidoo M West Afr J Med; 1994; 13(3):164-7. PubMed ID: 7841107 [TBL] [Abstract][Full Text] [Related]
10. Use of human immunodeficiency virus (HIV) type 1 and 2 recombinant strip immunoblot assay to resolve enzyme immunoassay anti-HIV-2-repeatably reactive samples after anti-HIV-1/2 combination enzyme immunoassay screening. Tobler LH; Kaufman E; Gefter N; Schable C; Busch MP Transfusion; 1997 Sep; 37(9):921-5. PubMed ID: 9308638 [TBL] [Abstract][Full Text] [Related]
11. The accuracy of an alternative confirmatory strategy for detection of antibodies to HIV-1: experience from a regional laboratory in Kagera, Tanzania. Urassa W; Godoy K; Killewo J; Kwesigabo G; Mbakileki A; Mhalu F; Biberfeld G J Clin Virol; 1999 Sep; 14(1):25-9. PubMed ID: 10548127 [TBL] [Abstract][Full Text] [Related]
12. Confirmation and differentiation of antibodies to human immunodeficiency virus 1 and 2 with a strip-based assay including recombinant antigens and synthetic peptides. Pollet DE; Saman EL; Peeters DC; Warmenbol HM; Heyndrickx LM; Wouters CJ; Beelaert G; van der Groen G; Van Heuverswyn H Clin Chem; 1991 Oct; 37(10 Pt 1):1700-7. PubMed ID: 1914169 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of a new dot blot assay for confirmation of human immunodeficiency virus type 1 and 2 infections using recombinant p24, gp41, gp120 and gp36 antigens. Ravanshad M; Sabahi F; Mahboudi F; Kazemnejad A Saudi Med J; 2006 Jan; 27(1):31-6. PubMed ID: 16432590 [TBL] [Abstract][Full Text] [Related]
14. Comparison of alternative interpretive criteria for the HIV-1 Western blot and results of the Multispot HIV-1/HIV-2 Rapid Test for classifying HIV-1 and HIV-2 infections. Nasrullah M; Ethridge SF; Delaney KP; Wesolowski LG; Granade TC; Schwendemann J; Boromisa RD; Heffelfinger JD; Owen SM; Branson BM J Clin Virol; 2011 Dec; 52 Suppl 1():S23-7. PubMed ID: 21993309 [TBL] [Abstract][Full Text] [Related]
15. Field evaluation of rapid HIV serologic tests for screening and confirming HIV-1 infection in Honduras. Stetler HC; Granade TC; Nunez CA; Meza R; Terrell S; Amador L; George JR AIDS; 1997 Mar; 11(3):369-75. PubMed ID: 9147429 [TBL] [Abstract][Full Text] [Related]
16. Incidence of dual presence of antibodies to HIV1 and HIV2 in seropositive cases seen in Ibadan, Nigeria. Shokunbi WA; Saliu I; Essien EM Afr J Med Med Sci; 1995 Sep; 24(3):249-53. PubMed ID: 8798960 [TBL] [Abstract][Full Text] [Related]
17. Discrimination between antibodies to HIV-1 and HIV-2 in sera from northern Zaire. Lackner F; Wewalka G; Heinz FX; Prinz A; Stanek G; Werner A; Kebela-Ilunga Zentralbl Bakteriol; 1990 Apr; 272(4):554-64. PubMed ID: 2360974 [TBL] [Abstract][Full Text] [Related]
18. No evidence of HIV 2 infection in Sicily. Russo Alesi D; Vitale F; Lupo G; La Licata R; Zambito F; Romano N Microbiologica; 1989 Jul; 12(3):195-201. PubMed ID: 2674633 [TBL] [Abstract][Full Text] [Related]
19. A comparison of the Genie and western blot assays in confirmatory testing for HIV-1 antibody. Chan EL; Sidaway F; Horsman GB J Med Microbiol; 1996 Mar; 44(3):223-5. PubMed ID: 8636942 [TBL] [Abstract][Full Text] [Related]
20. HIV seropositivity among female prostitutes and nonprostitutes: obstetric and perinatal implications. Obi CL; Ogbonna BA; Igumbor EO; Ndip RN; Ajayi AO Viral Immunol; 1993; 6(3):171-4. PubMed ID: 8292224 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]